Patent 7557191 was granted and assigned to Smithkline Beecham Limited on July, 2009 by the United States Patent and Trademark Office.
Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2. These antibodies are useful as diagnostic and therapeutic reagents.